Connect Biopharma Topline Results for CBP-201 China Pivotal Trial in Atopic Dermatitis | Connect Biopharma Holdings Ltd

Connect Biopharma Topline Results for CBP-201 China Pivotal Trial in Atopic Dermatitis

October 4, 2022 at 8:30 AM EDT

Click here for webcast

Supporting Materials

Connect Biopharma Topline Results for CBP-201 China Pivotal Trial in Atopic Dermatitis Presentation 886.7 KB